The Delta Plus variant of COVID-19: Will it be the worst nightmare in the SARS-CoV-2 pandemic?
DOI:
https://doi.org/10.3126/jbs.v8i1.38449Keywords:
Antiviral, chloroquine, drug, infection, SARS-CoV-2, treatment, trials, virusAbstract
No abstract available.
Downloads
Download data is not yet available.
Abstract
431
PDF
1221
Downloads
Published
2021-07-16
How to Cite
Roy, B., & Roy, H. (2021). The Delta Plus variant of COVID-19: Will it be the worst nightmare in the SARS-CoV-2 pandemic?. Journal of Biomedical Sciences, 8(1), 1–2. https://doi.org/10.3126/jbs.v8i1.38449
Issue
Section
Editorial
License
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.